Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'D-1 DOPAMINE-RECEPTORS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 144 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kindlundh, AMS; Lindblom, J; Bergstrom, L; Wikberg, JES; Nyberg, F
      The anabolic-androgenic steroid nandrolone decanoate affects the density of dopamine receptors in the male rat brain

      EUROPEAN JOURNAL OF NEUROSCIENCE
    2. Uslaner, J; Badiani, A; Norton, CS; Day, HEW; Watson, SJ; Akil, H; Robinson, TE
      Amphetamine and cocaine induce different patterns of c-fos mRNA expressionin the striatum and subthalamic nucleus depending on environmental context

      EUROPEAN JOURNAL OF NEUROSCIENCE
    3. Zeng, BY; Pearce, RKB; MacKenzie, GM; Jenner, P
      Chronic high dose L-dopa treatment does not alter the levels of dopamine D-1, D-2 or D-3 receptor in the striatum of normal monkeys: an autoradiographic study

      JOURNAL OF NEURAL TRANSMISSION
    4. Hirvonen, J; Nagren, T; Kajander, J; Hietala, J
      Measurement of cortical dopamine D-1 receptor binding with [C-11]SCH 23390: A test-retest analysis

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    5. Panchalingam, S; Undie, AS
      SKF83959 exhibits biochemical agonism by stimulating [S-35]GTP gamma S binding and phosphoinositide hydrolysis in rat and monkey brain

      NEUROPHARMACOLOGY
    6. Asghar, M; Hussain, T; Lokhandwala, MF
      Activation of dopamine D-1-like receptor causes phosphorylation of alpha(1)-subunit of Na+,K+-ATPase in rat renal proximal tubules

      EUROPEAN JOURNAL OF PHARMACOLOGY
    7. Arias-Montano, JA; Floran, B; Garcia, M; Aceves, J; Young, JM
      Histamine H-3 receptor-mediated inhibition of depolarization-induced, dopamine D-1 receptor-dependent release of [H-3]-gamma-aminobutyric acid from rat striatal slices

      BRITISH JOURNAL OF PHARMACOLOGY
    8. Salmi, P; Ahlenius, S
      Sedative effects of the dopamine D-1 receptor agonist A 68930 on rat open-field behavior

      NEUROREPORT
    9. Popoli, P; Reggio, R; Pezzola, A
      Effects of SCH 58261, an adenosine A(2A) receptor antagonist, on quinpirole-induced turning in 6-hydroxydopamine-lesioned rats: Lack of tolerance after chronic caffeine intake

      NEUROPSYCHOPHARMACOLOGY
    10. Naidu, PS; Kulkarni, SK
      Differential role of dopamine D-1 and D-2 receptors in isoniazid-induced vacuous chewing movements

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    11. Puschban, Z; Scherfler, C; Granata, R; Laboyrie, P; Quinn, NP; Jenner, P; Poewe, W; Wenning, GK
      Autoradiographic study of striatal dopamine re-uptake sites and dopamine D-1 and D-2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts

      NEUROSCIENCE
    12. Turner, TY; Soliman, MRI
      Effects of zinc on spatial reference memory and brain dopamine (D-1) receptor binding kinetics in rats

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    13. Meschler, JP; Conley, TJ; Howlett, AC
      Cannabinoid and dopamine interaction in rodent brain: effects on locomotoractivity

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    14. Fredholm, BB; Arslan, G; Halldner, L; Kull, B; Schulte, G; Wasserman, W
      Structure and function of adenosine receptors and their genes

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    15. Soares, HC; Reis, RAD; De Mello, FG; Ventura, ALM; Kurtenbach, E
      Differential expression of D-1A and D-1B dopamine receptor mRNAs in the developing avian retina

      JOURNAL OF NEUROCHEMISTRY
    16. Gurevich, EV; Joyce, JN
      Dopamine D-3 receptor is selectively and transiently expressed in the developing whisker barrel cortex of the rat

      JOURNAL OF COMPARATIVE NEUROLOGY
    17. Hoare, SRJ; Coldwell, MC; Armstrong, D; Strange, PG
      Regulation of human D-1, D-2(long), D-2(short), D-3 and D-4 dopamine receptors by amiloride and amiloride analogues

      BRITISH JOURNAL OF PHARMACOLOGY
    18. Gambarana, C; Mangiavacchi, S; Masi, F; Scheggi, S; Tagliamonte, A; Tolu, P; De Montis, MG
      Long-term lithium administration abolishes the resistance to stress in rats sensitized to morphine

      BRAIN RESEARCH
    19. Scheggi, S; Masi, F; Tagliamonte, A; Gambarana, C; Tolu, P; De Montis, MG
      Rats sensitized to morphine are resistant to the behavioral effects of an unavoidable stress

      BRAIN RESEARCH
    20. Voikar, V; Soosaar, A; Volke, V; Koks, S; Bourin, M; Mannisto, PT; Vasar, E
      Apomorphine-induced behavioural sensitization in rats: individual differences, role of dopamine and NMDA receptors

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    21. Goldman-Rakic, PS
      The relevance of the dopamine-D-1 receptor in the cognitive symptoms of schizophrenia

      NEUROPSYCHOPHARMACOLOGY
    22. Schmidt-Mutter, C; Muller, C; Zwiller, J; Gobaille,S; Maitre, M
      Gamma-hydroxybutyrate and cocaine administration increases mRNA expressionof dopamine D-1 and D-2 receptors in rat brain

      NEUROPSYCHOPHARMACOLOGY
    23. Gambarana, C; Ghiglieri, O; Tolu, P; De Montis, MG; Giachetti, D; Bombardelli, E; Tagliamonte, A
      Efficacy of an Hypericum perforatum (St. John's Wort) extract in preventing and reverting a condition of escape deficit in rats

      NEUROPSYCHOPHARMACOLOGY
    24. Meyer, JS; Kunkle, R
      Behavioral responses to a D-1 dopamine agonist in weanling rats treated neonatally with cocaine and Delta(9)-tetrahydrocannabinol

      NEUROTOXICOLOGY AND TERATOLOGY
    25. Clifford, JJ; Tighe, O; Croke, DT; Kinsella, A; Sibley, DR; Drago, J; Waddington, JL
      Conservation of behavioural topography to dopamine D-1-like receptor agonists in mutant mice lacking the D-1A receptor implicates a D-1-like receptornot coupled to adenylyl cyclase

      NEUROSCIENCE
    26. Lindskog, M; Svenningsson, P; Fredholm, BB; Greengard, P; Fisone, G
      Activation of dopamine D-2 receptors decreases DARPP-32 phosphorylation instriatonigral and striatopallidal projection neurons via different mechanisms

      NEUROSCIENCE
    27. Elwan, MA; Ishii, T; Ono, F; Sakuragawa, N
      Evidence for the presence of dopamine D-1 receptor mRNA and binding sites in monkey amniotic epithelial cells

      NEUROSCIENCE LETTERS
    28. Cavallotti, C; Pescosolido, N; Artico, M; Feher, J
      Localization of dopamine receptors in the rabbit cornea

      CORNEA
    29. Liu, ZH; Zhang, KG
      Dihydroetorphine-induced place preference was mediated by dopamine D-1 receptors in rats

      ACTA PHARMACOLOGICA SINICA
    30. Sanudo-Pena, MC; Force, M; Kang, T; McLemore, G; Roberts, L; Walker, JM
      Dopaminergic system does not play a major role in the precipitated cannabinoid withdrawal syndrome

      ACTA PHARMACOLOGICA SINICA
    31. Chen, LJ; Zhou, QT; Dong, ZJ; Yu, LP; Jin, GZ
      Comparison of 12-chloroscoulerine enantiomers on animal behavior to dopamine receptors

      ACTA PHARMACOLOGICA SINICA
    32. Scalzitti, JM; Cervera, LS; Smith, C; Hensler, JG
      Serotonin(2A) receptor modulation of D-1 dopamine receptor-mediated grooming behavior

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    33. Kitamura, M; Koshikawa, N; Yoneshige, N; Cools, AR
      Behavioural and neurochemical effects of cholinergic and dopaminergic agonists administered into the accumbal core and shell in rats

      NEUROPHARMACOLOGY
    34. Meloni, EG; Davis, M
      Enhancement of the acoustic startle response in rats by the dopamine D-1 receptor agonist SKF 82958

      PSYCHOPHARMACOLOGY
    35. HAUBER W; NAGEL J; SAUER R; MULLER CE
      MOTOR EFFECTS INDUCED BY A BLOCKADE OF ADENOSINE A(2A) RECEPTORS IN THE CAUDATE-PUTAMEN

      NeuroReport
    36. Hauber, W
      Blockade of subthalamic dopamine D-1 receptors elicits akinesia in rats

      NEUROREPORT
    37. GRINSHPOON A; MOSKOWITZ M; VALEVSKI A; KREIZMAN A; PALEI L; MARK M; WEIZMAN A
      ZUCLOPENTHIXOL, D-1 D-2 ANTAGONIST, FOR TREATMENT OF CHRONIC AGGRESSIVE SCHIZOPHRENIA AND PSYCHOTIC OLIGOPHRENIC PATIENTS/

      European psychiatry
    38. WHITE FJ; JOSHI A; KOELTZOW TE; HU XT
      DOPAMINE-RECEPTOR ANTAGONISTS FAIL TO PREVENT INDUCTION OF COCAINE SENSITIZATION

      Neuropsychopharmacology
    39. KOSTICRAJACIC S; SOSKIC V; JOKSIMOVIC J
      MIXED DOPAMINERGIC SEROTONERGIC PROPERTIES OF SEVERAL 2-SUBSTITUTED 4-[2-(5-BENZIMIDAZOLE)ETHYL]-1-ARYLPIPERAZINES/

      Archiv der pharmazie
    40. SVENNINGSSON P; LINDSKOG M; ROGNONI F; FREDHOLM BB; GREENGARD P; FISONE G
      ACTIVATION OF ADENOSINE A(2A) AND DOPAMINE D-1 RECEPTORS STIMULATES CYCLIC-AMP-DEPENDENT PHOSPHORYLATION OF DARPP-32 IN DISTINCT POPULATIONS OF STRIATAL PROJECTION NEURONS

      Neuroscience
    41. Morelli, M; Fenu, S
      Role of dopamine receptors in the induction and expression of rotational behavior induced by caffeine in 6-hydroxydopamine-lesioned rats

      DRUG DEVELOPMENT RESEARCH
    42. GUO X; LIU J; ZOU LL; JIN J; WANG BC; JIN GZ
      ENHANCEMENT OF (-)-STEPHOLIDINE ON PROTEIN-PHOSPHORYLATION OF A DOPAMINE-REGULATED AND CAMP-REGULATED PHOSPHOPROTEIN IN DENERVATED STRIATUMOF OXIDOPAMINE-LESIONED RATS

      Zhongguo yaoli xuebao
    43. Halldin, C; Foged, C; Chou, YH; Karlsson, P; Swahn, CG; Sandell, J; Sedvall, G; Farde, L
      Carbon-11-NNC 112: A radioligand for PET examination of striatal and neocortical D-1-dopamine receptors

      JOURNAL OF NUCLEAR MEDICINE
    44. ALLEN SM; FREEMAN JN; DAVIS WM
      EVALUATION OF RISPERIDONE IN THE NEONATAL 6-HYDROXYDOPAMINE MODEL OF LESCH-NYHAN-SYNDROME

      Pharmacology, biochemistry and behavior
    45. Clifford, JJ; Tighe, O; Croke, DT; Sibley, DR; Drago, J; Waddington, JL
      Topographical evaluation of the phenotype of spontaneous behaviour in micewith targeted gene deletion of the D-1A dopamine receptor: paradoxical elevation of grooming syntax

      NEUROPHARMACOLOGY
    46. SALMI P; MALMGREN K; SVENSSON TH; AHLENIUS S
      STIMULATION OF FORWARD LOCOMOTION BY SCH-23390 AND RACLOPRIDE IN D-AMPHETAMINE-TREATED RATS

      Naunyn-Schmiedeberg's archives of pharmacology
    47. GUO X; DING YM; HU JY; JIN GZ
      INVOLVEMENT OF DOPAMINE D-1 AND D-2 RECEPTORS IN FOS IMMUNOREACTIVITYINDUCED BY STEPHOLIDINE IN BOTH INTACT AND DENERVATED STRIATUM OF LESIONED RATS

      Life sciences
    48. JACKSON DM; WALLSTEN CE; JERNING E; HU PS; DEVENEY AM
      2 SELECTIVE 5-HT1A RECEPTOR ANTAGONISTS, WAY-100-635 AND NDL-249, STIMULATE LOCOMOTION IN RATS ACCLIMATIZED TO THEIR ENVIRONMENT AND ALTER THEIR BEHAVIOR - A BEHAVIORAL-ANALYSIS

      Psychopharmacology
    49. BERENYI S; CSUTORAS C; MAKLEIT S; AUTH F; LASZLOVSZKY I; KISS B; KARPATI E; LOW M
      SYNTHESIS AND NEUROPHARMACOLOGICAL EVALUATION OF NEW (R)-(-)-2-(ALKYLTHIO)APORPHINE AND (S)-(-2-(ALKYLTHIO)APORPHINE DERIVATIVES())

      Medicinal chemistry research
    50. ARDENGHI P; BARROS D; IZQUIERDO LA; BEVILAQUA L; SCHRODER N; QUEVEDO J; RODRIGUES C; MADRUGA M; MEDINA JH; IZQUIERDO I
      LATE AND PROLONGED POST-TRAINING MEMORY MODULATION IN ENTORHINAL AND PARIETAL CORTEX BY DRUGS ACTING ON THE CAMP PROTEIN KINASE-A SIGNALINGPATHWAY/

      Behavioural pharmacology
    51. BEVILAQUA L; ARDENGHI P; SCHRODER N; BROMBERG E; SCHMITZ PK; SCHAEFFER E; QUEVEDO J; BIANCHIN M; WALZ R; MEDINA JH; IZQUIERDO I
      DRUGS ACTING UPON THE CYCLIC ADENOSINE-MONOPHOSPHATE PROTEIN-KINASE-ASIGNALING PATHWAY MODULATE MEMORY CONSOLIDATION WHEN GIVEN LATE AFTERTRAINING INTO RAT HIPPOCAMPUS BUT NOT AMYGDALA

      Behavioural pharmacology
    52. TOMIC M; VUKOSAVIC S; JOKSIMOVIC J
      ACUTE AMPHETAMINE AND OR PHENCYCLIDINE EFFECTS ON THE DOPAMINE-RECEPTOR SPECIFIC BINDING IN THE RAT-BRAIN/

      European neuropsychopharmacology
    53. HARVEY J; LACEY MG
      A POSTSYNAPTIC INTERACTION BETWEEN DOPAMINE D-1 AND NMDA RECEPTORS PROMOTES PRESYNAPTIC INHIBITION IN THE RAT NUCLEUS-ACCUMBENS VIA ADENOSINE RELEASE

      The Journal of neuroscience
    54. WANG YQ; CAO XD; LI KY; WU GH
      RELATIONSHIP BETWEEN ELECTROACUPUNCTURE ANALGESIA AND DOPAMINE-RECEPTORS IN NUCLEUS-ACCUMBENS

      Zhongguo yaoli xuebao
    55. GUO X; WANG LM; LIU J; JIN GZ
      CHARACTERISTICS OF TETRAHYDROPROTOBERBERINES ON DOPAMINE D-1 AND D-2 RECEPTORS IN CALF STRIATUM

      Zhongguo yaoli xuebao
    56. BEVILAQUA L; ARDENGHI P; SCHRODER N; BROMBERG E; QUEVEDO J; SCHMITZ PK; BIANCHIN M; WALZ R; SCHAEFFER E; MEDINA JH; IZQUIERDO I
      AGENTS THAT AFFECT CAMP LEVELS OR PROTEIN-KINASE-A ACTIVITY MODULATE MEMORY CONSOLIDATION WHEN INJECTED INTO RAT HIPPOCAMPUS BUT NOT AMYGDALA

      Brazilian journal of medical and biological research
    57. DEVENEY AM; WADDINGTON JL
      PSYCHOPHARMACOLOGICAL DISTINCTION BETWEEN NOVEL FULL-EFFICACY D-1-LIKE DOPAMINE-RECEPTOR AGONISTS

      Pharmacology, biochemistry and behavior
    58. DIAZOTANEZ CS; CAPRILES ND; CANCELA LM
      D-1 AND D-2 DOPAMINE AND OPIATE RECEPTORS ARE INVOLVED IN THE RESTRAINT STRESS-INDUCED SENSITIZATION TO THE PSYCHOSTIMULANT EFFECTS OF AMPHETAMINE

      Pharmacology, biochemistry and behavior
    59. BRUS R; SZKILNIK R; NOWAK P; KOSTRZEWA RM
      NITRO-L-ARGININE ATTENUATES SKF 38393-INDUCED ORAL ACTIVITY IN NEONATAL 6-HYDROXYDOPAMINE-LESIONED RATS

      Acta Neurobiologiae Experimentalis
    60. GILMARTIN E; FERNANDEZBRIERA A; CALVO P
      EFFECTS OF CHRONIC ETHANOL TREATMENT AND ETHANOL WITHDRAWAL ON [H-3] SCH23390 BINDING TO RAT STRIATAL MEMBRANES

      Neuropharmacology
    61. FICI GJ; WU H; VONVOIGTLANDER PF; SETHY VH
      D-1 DOPAMINE-RECEPTOR ACTIVITY OF ANTI-PARKINSONIAN DRUGS

      Life sciences
    62. ZHANG L; JOSEPH JA; ROTH GS
      EFFECT OF AGING ON VULNERABILITY OF STRIATAL D-1 AND D-2 DOPAMINE RECEPTOR-CONTAINING NEURONS TO KAINIC ACID

      Brain research
    63. WOLTERS EC
      THE ROLE OF D-1 AND D-2 DOPAMINE-RECEPTORS IN MOTOR BEHAVIOR OF PATIENTS WITH PARKINSONS-DISEASE

      European journal of neurology
    64. PELLEVOISIN C; CHALON S; KUNG HF; BESNARD JC; GUILLOTEAU D
      IS TISCH A SUITABLE TRACER FOR IN-VIVO STUDY OF MODIFICATIONS OF THE DOPAMINE D-1 RECEPTOR

      Nuclear medicine and biology
    65. SUN BC; CHOUVET G; JIN GZ
      D-1 DOPAMINE-RECEPTOR STIMULATION INHIBITS FIRING ACTIVITY OF MIDBRAIN DOPAMINE NEURONS IN RESERPINE TREATED RATS - AN EFFECT ELIMINATED AFTER HEMITRANSECTION OF DIENCEPHALON

      Synapse
    66. HAUBER W
      IMPAIRMENTS OF MOVEMENT INITIATION AND EXECUTION INDUCED BY A BLOCKADE OF DOPAMINE D-1 OR D-2 RECEPTORS ARE REVERSED BY A BLOCKADE OF N-METHYL-D-ASPARTATE RECEPTORS

      Neuroscience
    67. FRIEDMAN E; YADIN E; WANG HY
      EFFECT OF PRENATAL COCAINE ON DOPAMINE RECEPTOR-G PROTEIN COUPLING INMESOCORTICAL REGIONS OF THE RABBIT BRAIN

      Neuroscience
    68. WADDINGTON JL; DEVENEY AM
      DOPAMINE-RECEPTOR MULTIPLICITY - D-1-LIKE-D-2-LIKE INTERACTIONS AND D-1-LIKE RECEPTORS NOT LINKED TO ADENYLATE-CYCLASE

      Biochemical Society transactions
    69. ACRI JB; SHAH JH; NEWMAN AH; BELOV YP; BASILE AS; SHARPE LG; WITKIN JM
      BEHAVIORAL-EFFECTS AND DOPAMINE ANTAGONIST PROPERTIES OF N-ALKYLAMINOBENZAZEPINES

      Drug development research
    70. ZOU LL; CAI ST; JIN GZ
      CHRONIC TREATMENT WITH (-)-STEPHOLIDINE ALTERS DENSITY AND TURNOVER OF D-1 AND D-2 RECEPTORS IN STRIATUM

      Zhongguo yaoli xuebao
    71. HASKO G; SZABO C; MERKEL K; BENCSICS A; ZINGARELLI B; KVETAN V; VIZI ES
      MODULATION OF LIPOPOLYSACCHARIDE-INDUCED TUMOR-NECROSIS-FACTOR-ALPHA AND NITRIC-OXIDE PRODUCTION BY DOPAMINE-RECEPTOR AGONISTS AND ANTAGONISTS IN MICE

      Immunology letters
    72. VAUGEOIS JM; POUHE D; ZUCCARO F; COSTENTIN J
      INDIRECT DOPAMINE AGONISTS EFFECTS ON DESPAIR TEST - DISSOCIATION FROM HYPERACTIVITY

      Pharmacology, biochemistry and behavior
    73. NEISEWANDER JL; LUCKI I; MCGONIGLE P
      CHANGES IN BEHAVIORAL SENSITIVITY TO SKF-38393 AND QUINPIROLE FOLLOWING WITHDRAWAL FROM CONTINUOUS COCAINE ADMINISTRATION IN RATS

      Pharmacology, biochemistry and behavior
    74. THIBAUT F; VAUGEOIS JM; BONNET JJ; COSTENTIN J
      IN-VIVO STRIATAL BINDING OF THE D-1 ANTAGONIST SCH-23390 IS NOT MODIFIED BY CHANGES IN DOPAMINERGIC TRANSMISSION

      Neuropharmacology
    75. DEVENEY AM; WADDINGTON JL
      EVIDENCE FOR DOPAMINE D-1-LIKE RECEPTOR SUBTYPES IN THE BEHAVIORAL-EFFECTS OF 2 NEW SELECTIVE ANTAGONISTS, LY-270411 AND BW-737C

      European journal of pharmacology
    76. VANDERGRAAF PH; SHANKLEY NP; BLACK JW
      ANALYSIS OF THE EFFECTS OF ALPHA(1)-ADRENOCEPTOR ANTAGONISTS ON NORADRENALINE-MEDIATED CONTRACTION OF RAT SMALL MESENTERIC-ARTERY

      British Journal of Pharmacology
    77. OLIANAS MC; ONALI P
      ANTAGONISM OF STRIATAL MUSCARINIC RECEPTORS INHIBITING DOPAMINE D-1 RECEPTOR-STIMULATED ADENYLYL-CYCLASE ACTIVITY BY CHOLINOCEPTOR ANTAGONISTS USED TO TREAT PARKINSONS-DISEASE

      British Journal of Pharmacology
    78. RYU JH; YANAI K; ZHAO XL; WATANABE T
      THE EFFECT OF DOPAMINE D-1 RECEPTOR STIMULATION ON THE UP-REGULATION OF HISTAMINE H-3 RECEPTORS FOLLOWING DESTRUCTION OF THE ASCENDING DOPAMINERGIC-NEURONS

      British Journal of Pharmacology
    79. KOSHIKAWA N; KITAMURA M; KOBAYASHI M; COOLS AR
      CONTRALATERAL TURNING ELICITED BY UNILATERAL STIMULATION OF DOPAMINE D-1 AND D-2 RECEPTORS IN THE NUCLEUS-ACCUMBENS OF RATS IS DUE TO STIMULATION OF THESE RECEPTORS IN THE SHELL, BUT NOT THE CORE, OF THIS NUCLEUS

      Psychopharmacology
    80. SUZUKI T; TSUJI M; MORI T; MISAWA M; NAGASE H
      THE EFFECTS OF DOPAMINE D-1 AND D-2 RECEPTOR ANTAGONISTS ON THE REWARDING EFFECTS OF DELTA(1) AND DELTA(2) OPIOID RECEPTOR AGONISTS IN MICE

      Psychopharmacology
    81. DEVENEY AM; WADDINGTON JL
      COMPARISON OF THE NEW ATYPICAL ANTIPSYCHOTICS OLANZAPINE AND ICI-204,636 WITH CLOZAPINE ON BEHAVIORAL-RESPONSES TO THE SELECTIVE D-1 LIKE DOPAMINE-RECEPTOR AGONIST A-68930 AND SELECTIVE D-2-LIKE AGONIST RU-24213

      Psychopharmacology
    82. LAWLER CP; GILMORE JH; WATTS VJ; WALKER QD; SOUTHERLAND SB; COOK LL; MATHIS CA; MAILMAN RB
      INTERHEMISPHERIC MODULATION OF DOPAMINE-RECEPTOR INTERACTIONS IN UNILATERAL 6-OHDA RODENT MODEL

      Synapse
    83. SLOBODYANSKY E; AOKI Y; GAZNABI AKM; AVILES DH; FILDES RD; JOSE PA
      DOPAMINE AND PROTEIN PHOSPHATASE-ACTIVITY IN RENAL PROXIMAL TUBULES

      American journal of physiology. Renal, fluid and electrolyte physiology
    84. TANI Y; ISHIHARA T; KANAI T; OHNO T; ANDERSSON J; LILJA A; ANTONI G; FASTH KJ; BJURLING P; WESTERBERG G; HARTVIG P; ONOE H; WATANABE Y; LANGSTROM B
      EFFECTS OF 6R-L-ERYTHRO-5,6,7,8-TETRAHYDROBIOPTERIN ON THE DOPAMINERGIC AND CHOLINERGIC RECEPTORS AS EVALUATED BY POSITRON EMISSION TOMOGRAPHY IN THE RHESUS-MONKEY

      Journal of neural transmission
    85. HILAKIVI I; AHTEE L; RINNE JO; TAIRA T; ATTILA LMJ; MARJAMAKI P
      EFFECTS OF MONOAMINE UPTAKE INHIBITORS GIVEN EARLY POSTNATALLY ON MONOAMINES IN THE BRAIN-STEM, CAUDATE PUTAMEN AND CORTEX, AND ON DOPAMINED-1 AND D-2 RECEPTORS IN THE CAUDATE/PUTAMEN/

      Journal of neural transmission
    86. GAMBARANA C; GHIGLIERI O; DEMONTIS MG
      DESENSITIZATION OF THE D-1 DOPAMINE-RECEPTORS IN RATS REPRODUCES A MODEL OF ESCAPE DEFICIT REVERTED BY IMIPRAMINE, FLUOXETINE AND CLOMIPRAMINE

      Progress in neuro-psychopharmacology & biological psychiatry
    87. WADDINGTON JL; DALY SA; DOWNES RP; DEVENEY AM; MCCAULEY PG; OBOYLE KM
      BEHAVIORAL PHARMACOLOGY OF D-1-LIKE DOPAMINE-RECEPTORS - FURTHER SUBTYPING, NEW PHARMACOLOGICAL PROBES AND INTERACTIONS WITH D-2-LIKE RECEPTORS

      Progress in neuro-psychopharmacology & biological psychiatry
    88. LEZCANO NE; DEBARIOGLIO SR; CELIS ME
      ALPHA-MSH CHANGES CYCLIC-AMP LEVELS IN RAT-BRAIN SLICES BY AN INTERACTION WITH THE D-1 DOPAMINE-RECEPTOR

      Peptides
    89. CALLAHAN PM; BRYAN SK; CUNNINGHAM KA
      DISCRIMINATIVE STIMULUS EFFECTS OF COCAINE - ANTAGONISM BY DOPAMINE D-1 RECEPTOR BLOCKADE IN THE AMYGDALA

      Pharmacology, biochemistry and behavior
    90. UJIKE H; TSUCHIDA K; AKIYAMA K; FUJIWARA Y; KURODA S
      ONTOGENY OF BEHAVIORAL SENSITIZATION TO COCAINE

      Pharmacology, biochemistry and behavior
    91. BRUS R; PLECH A; KOSTRZEWA RM
      ENHANCED QUINPIROLE RESPONSE IN RATS LESIONED NEONATALLY WITH 5,7-DIHYDROXYTRYPTAMINE

      Pharmacology, biochemistry and behavior
    92. MOHELL N; GEORGIEV J; LARSSON LG; JACKSON DM; BENGTSSON A; MAGNUSSON O; ROSS SB
      TIME-COURSE OF BROMOCRIPTINE INDUCED EXCITATION IN THE RAT - BEHAVIORAL AND BIOCHEMICAL-STUDIES

      Naunyn-Schmiedeberg's archives of pharmacology
    93. FARRELL CB; LAWLOR M; DUNNE A; OBOYLE KM
      D-2 RECEPTOR ANTAGONISTS DO NOT MODIFY GUANINE-NUCLEOTIDE-SENSITIVE INTERACTIONS BETWEEN DOPAMINE AND D-1 DOPAMINE-RECEPTORS UNDER IN-VITROCONDITIONS

      Journal of neurochemistry
    94. VANDERGRAAF PH; SAXENA PR; SHANKLEY NP; BLACK JW
      EXPOSURE AND CHARACTERIZATION OF THE ACTION OF NORADRENALINE AT DOPAMINE-RECEPTORS MEDIATING ENDOTHELIUM-INDEPENDENT RELAXATION OF RAT ISOLATED SMALL MESENTERIC-ARTERIES

      British Journal of Pharmacology
    95. DEVENEY AM; WADDINGTON JL
      PHARMACOLOGICAL CHARACTERIZATION OF BEHAVIORAL-RESPONSES TO SK-AND-F-83959 IN RELATION TO D-1-LIKE DOPAMINE-RECEPTORS NOT LINKED TO ADENYLYL-CYCLASE

      British Journal of Pharmacology
    96. ZHANG SP; CONNELL TA; PRICE T; SIMPSON GM; ZHOU LW; WEISS B
      CONTINUOUS-INFUSION OF CLOZAPINE INCREASES MU-OPIOID AND DELTA-OPIOIDRECEPTORS AND PROENKEPHALIN MESSENGER-RNA IN MOUSE-BRAIN

      Biological psychiatry
    97. KARLSSON P; SEDVALL G; HALLDIN C; SWAHN CG; FARDE L
      EVALUATION OF SCH-39166 AS PET LIGAND FOR CENTRAL D-1 DOPAMINE-RECEPTOR BINDING AND OCCUPANCY IN MAN

      Psychopharmacology
    98. KARLSSON P; SMITH L; FARDE L; HARNRYD C; SEDVALL G; WIESEL FA
      LACK OF APPARENT ANTIPSYCHOTIC EFFECT OF THE D-1-DOPAMINE RECEPTOR ANTAGONIST SCH39166 IN ACUTELY ILL SCHIZOPHRENIC-PATIENTS

      Psychopharmacology
    99. KARLSSON P; FARDE L; HALLDIN C; SEDVALL G; YNDDAL L; SLOTHNIELSEN M
      ORAL-ADMINISTRATION OF NNC-756 - A PLACEBO-CONTROLLED PET STUDY OF D-1-DOPAMINE RECEPTOR OCCUPANCY AND PHARMACODYNAMICS IN MAN

      Psychopharmacology
    100. KURIBARA H
      INHIBITION OF METHAMPHETAMINE SENSITIZATION BY POST-METHAMPHETAMINE TREATMENT WITH SCH-23390 OR HALOPERIDOL

      Psychopharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 08/08/20 alle ore 15:30:53